Monetizing music is not an easy task, but Splice is finding success cracking the code. Splice's Co-Founder, Steve Martocci, joined us to discuss how the company is developing a creative hub for modern musicians.
Splice isn't Martocci's first company. He founded GroupMe in 2010 and sold it to Skype in 2011. While he is taking on a different industry, he shares that he orignally created GroupMe with the intention to make it easier for friends to go to concerts together. Martocci says software has always been his canvas, and music is the motivator. The entrepreneur tells us how his experience with the messaging application is helping him in his latest venture.
Martocci explains that the app works for everyone from GRAMMY nominated artists to brand new musicians. In fact, a sound from Demi Lovato's hit song "Sorry Not Sorry," was sampled from the Splice platform. It's not just music. The platform is used for all types of audio, including cinema.
Splice just raised $35 million, bringing total funding to $47 million. While the company has made a lot of progress, Martocci says there is a lot more to do. With the new funding, he plans to build the best team possible.
Conditions have been mostly nice for travelers flying ahead of and on Christmas Day, but some naughty disruptions plagued those flying with Southwest Airlines again this year.
Gift cards make great stocking stuffers — just as long as you don't stuff them in a drawer and forget about them after the holidays.
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Supermarket chain Ralphs is facing a new lawsuit from the state of California.
Shake Shack is giving out free fried chicken sandwiches, bacon cheese fries and milkshakes nationwide.
The IRS is announcing a voluntary disclosure program.
Lionsgate announced its studio division is going to spin off in a merger with Screaming Eagle Acquisition Corp., which is a special purpose acquisition company.
A new report suggests that it's getting more difficult for an average American to afford a home.
The Food and Drug Administration warned consumers about a copycat version of the diabetes drug Ozempic.
